CNBX Pharmaceuticals Inc.
CNBX
$0.0023
$0.000315.00%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 76.03% | 84.39% | 81.26% | 66.59% | 70.26% |
| Total Depreciation and Amortization | -100.00% | -79.23% | -55.34% | -35.11% | -16.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -93.56% | -93.10% | -91.71% | -76.38% | -80.80% |
| Change in Net Operating Assets | -50.30% | -70.65% | -71.90% | -43.32% | 334.22% |
| Cash from Operations | 28.51% | -139.37% | -117.16% | 37.88% | 69.61% |
| Capital Expenditure | 100.00% | 100.00% | -- | -9.09% | -9.09% |
| Sale of Property, Plant, and Equipment | 373.50% | -- | -- | 326.39% | -25.65% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -100.00% |
| Cash from Investing | 403.72% | 388.09% | 359.51% | 125.20% | -62.70% |
| Total Debt Issued | 7.24% | -73.92% | -72.40% | -50.62% | -74.38% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.24% | -73.92% | -72.40% | -50.62% | -74.38% |
| Foreign Exchange rate Adjustments | -200.00% | -- | -- | 100.00% | 1,322.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 180.19% | -207.17% | -952.89% | 156.13% | 94.24% |